欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Odontella sinensis Photosystem II reaction center psb28 protein (psb28) CSB-YP344204OAK
CSB-EP344204OAK
CSB-BP344204OAK
CSB-MP344204OAK
CSB-EP344204OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis Photosystem II reaction center protein T (psbT), partial CSB-YP344205OAK
CSB-EP344205OAK
CSB-BP344205OAK
CSB-MP344205OAK
CSB-EP344205OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis Photosystem I assembly protein ycf3 (ycf3) CSB-YP344206OAK
CSB-EP344206OAK
CSB-BP344206OAK
CSB-MP344206OAK
CSB-EP344206OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis Uncharacterized protein ycf35 (ycf35) CSB-YP344207OAK
CSB-EP344207OAK
CSB-BP344207OAK
CSB-MP344207OAK
CSB-EP344207OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis 50S ribosomal protein L1, chloroplastic (rpl1) CSB-YP344208OAK
CSB-EP344208OAK
CSB-BP344208OAK
CSB-MP344208OAK
CSB-EP344208OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP344209OAK
CSB-EP344209OAK
CSB-BP344209OAK
CSB-MP344209OAK
CSB-EP344209OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis 50S ribosomal protein L27, chloroplastic (rpl27) CSB-YP344210OAK
CSB-EP344210OAK
CSB-BP344210OAK
CSB-MP344210OAK
CSB-EP344210OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis 50S ribosomal protein L3, chloroplastic (rpl3) CSB-YP344211OAK
CSB-EP344211OAK
CSB-BP344211OAK
CSB-MP344211OAK
CSB-EP344211OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable protein phosphatase 2C F42G9.1 (F42G9.1) CSB-YP344212CXY
CSB-EP344212CXY
CSB-BP344212CXY
CSB-MP344212CXY
CSB-EP344212CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein phosphatase 2C 56 (ABI1) CSB-YP344213DOA
CSB-EP344213DOA
CSB-BP344213DOA
CSB-MP344213DOA
CSB-EP344213DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis Adenylate cyclase (UAC1), partial CSB-YP344214UBS
CSB-EP344214UBS
CSB-BP344214UBS
CSB-MP344214UBS
CSB-EP344214UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella haemolytica Arginine-binding periplasmic protein (lapT) CSB-YP344215ESE
CSB-EP344215ESE
CSB-BP344215ESE
CSB-MP344215ESE
CSB-EP344215ESE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ascaris suum cAMP-dependent protein kinase catalytic subunit (CAPK) CSB-YP344216DOS
CSB-EP344216DOS
CSB-BP344216DOS
CSB-MP344216DOS
CSB-EP344216DOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nicotiana tabacum Ribonucleoside-diphosphate reductase small chain CSB-YP344217NHE
CSB-EP344217NHE
CSB-BP344217NHE
CSB-MP344217NHE
CSB-EP344217NHE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Serine/threonine-protein kinase Doa (Doa), partial CSB-YP344218DLU
CSB-EP344218DLU
CSB-BP344218DLU
CSB-MP344218DLU
CSB-EP344218DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ARS-binding protein 1 (abp1), partial CSB-YP344219SXV
CSB-EP344219SXV
CSB-BP344219SXV
CSB-MP344219SXV
CSB-EP344219SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Stage III sporulation protein AH (spoIIIAH), partial CSB-YP344220BRJ
CSB-EP344220BRJ
CSB-BP344220BRJ
CSB-MP344220BRJ
CSB-EP344220BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis Uncharacterized protein ycf88 (ycf88) CSB-YP344221OAK
CSB-EP344221OAK
CSB-BP344221OAK
CSB-MP344221OAK
CSB-EP344221OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Odontella sinensis Uncharacterized protein ycf66 (ycf66) CSB-YP344222OAK
CSB-EP344222OAK
CSB-BP344222OAK
CSB-MP344222OAK
CSB-EP344222OAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Flavohemoprotein (hmp) CSB-YP344223BRJ
CSB-EP344223BRJ
CSB-BP344223BRJ
CSB-MP344223BRJ
CSB-EP344223BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×